The global Human Rabies Vaccine (Vero Cell) market was valued at 391 million in 2024 and is projected to reach US$ 561 million by 2031, at a CAGR of 5.4% during the forecast period.
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Vaccine (Vero Cell) manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine (Vero Cell). This report contains market size and forecasts of Human Rabies Vaccine (Vero Cell) in global, including the following market information:
Global Human Rabies Vaccine (Vero Cell) market revenue, 2020-2025, 2026-2031, ($ millions)
Global Human Rabies Vaccine (Vero Cell) market sales, 2020-2025, 2026-2031, (K Units)
Global top five Human Rabies Vaccine (Vero Cell) companies in 2024 (%)
Total Market by Segment:
Global Human Rabies Vaccine (Vero Cell) market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) market segment percentages, by Type, 2024 (%)
0.5ml
1ml
Global Human Rabies Vaccine (Vero Cell) market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Human Rabies Vaccine (Vero Cell) market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Vaccine (Vero Cell) revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Human Rabies Vaccine (Vero Cell) revenues share in global market, 2024 (%)
Key companies Human Rabies Vaccine (Vero Cell) sales in global market, 2020-2025 (estimated), (K Units)
Key companies Human Rabies Vaccine (Vero Cell) sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rongan
Hualan Bio-vaccine
Sanofi Pasteur SA
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Rabies Vaccine (Vero Cell), market overview.
Chapter 2: Global Human Rabies Vaccine (Vero Cell) market size in revenue and volume.
Chapter 3: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Rabies Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Rabies Vaccine (Vero Cell) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Human Rabies Vaccine (Vero Cell) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Human Rabies Vaccine (Vero Cell) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Rabies Vaccine (Vero Cell) Overall Market Size
2.1 Global Human Rabies Vaccine (Vero Cell) Market Size: 2024 VS 2031
2.2 Global Human Rabies Vaccine (Vero Cell) Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Human Rabies Vaccine (Vero Cell) Sales: 2020-2031
3 Company Landscape
3.1 Top Human Rabies Vaccine (Vero Cell) Players in Global Market
3.2 Top Global Human Rabies Vaccine (Vero Cell) Companies Ranked by Revenue
3.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Companies
3.4 Global Human Rabies Vaccine (Vero Cell) Sales by Companies
3.5 Global Human Rabies Vaccine (Vero Cell) Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Human Rabies Vaccine (Vero Cell) Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Human Rabies Vaccine (Vero Cell) Product Type
3.8 Tier 1, Tier 2, and Tier 3 Human Rabies Vaccine (Vero Cell) Players in Global Market
3.8.1 List of Global Tier 1 Human Rabies Vaccine (Vero Cell) Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Rabies Vaccine (Vero Cell) Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Market Size Markets, 2024 & 2031
4.1.2 0.5ml
4.1.3 1ml
4.2 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
4.2.1 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue, 2020-2025
4.2.2 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue, 2026-2031
4.2.3 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
4.3.1 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales, 2020-2025
4.3.2 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales, 2026-2031
4.3.3 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
4.4 Segment by Type - Global Human Rabies Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Market Size, 2024 & 2031
5.1.2 Hospital
5.1.3 Clinic
5.2 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
5.2.1 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue, 2020-2025
5.2.2 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue, 2026-2031
5.2.3 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
5.3.1 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales, 2020-2025
5.3.2 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales, 2026-2031
5.3.3 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
5.4 Segment by Application - Global Human Rabies Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Human Rabies Vaccine (Vero Cell) Market Size, 2024 & 2031
6.2 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
6.2.1 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, 2020-2025
6.2.2 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, 2026-2031
6.2.3 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
6.3 By Region - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
6.3.1 By Region - Global Human Rabies Vaccine (Vero Cell) Sales, 2020-2025
6.3.2 By Region - Global Human Rabies Vaccine (Vero Cell) Sales, 2026-2031
6.3.3 By Region - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Human Rabies Vaccine (Vero Cell) Revenue, 2020-2031
6.4.2 By Country - North America Human Rabies Vaccine (Vero Cell) Sales, 2020-2031
6.4.3 United States Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.4.4 Canada Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.4.5 Mexico Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Human Rabies Vaccine (Vero Cell) Revenue, 2020-2031
6.5.2 By Country - Europe Human Rabies Vaccine (Vero Cell) Sales, 2020-2031
6.5.3 Germany Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.4 France Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.5 U.K. Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.6 Italy Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.7 Russia Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.8 Nordic Countries Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.5.9 Benelux Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Human Rabies Vaccine (Vero Cell) Revenue, 2020-2031
6.6.2 By Region - Asia Human Rabies Vaccine (Vero Cell) Sales, 2020-2031
6.6.3 China Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.6.4 Japan Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.6.5 South Korea Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.6.6 Southeast Asia Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.6.7 India Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Human Rabies Vaccine (Vero Cell) Revenue, 2020-2031
6.7.2 By Country - South America Human Rabies Vaccine (Vero Cell) Sales, 2020-2031
6.7.3 Brazil Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.7.4 Argentina Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales, 2020-2031
6.8.3 Turkey Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.8.4 Israel Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.8.5 Saudi Arabia Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
6.8.6 UAE Human Rabies Vaccine (Vero Cell) Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Liaoning Chengda
7.1.1 Liaoning Chengda Company Summary
7.1.2 Liaoning Chengda Business Overview
7.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.1.5 Liaoning Chengda Key News & Latest Developments
7.2 Guangzhou Nuocheng
7.2.1 Guangzhou Nuocheng Company Summary
7.2.2 Guangzhou Nuocheng Business Overview
7.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.2.5 Guangzhou Nuocheng Key News & Latest Developments
7.3 Ningbo Rongan
7.3.1 Ningbo Rongan Company Summary
7.3.2 Ningbo Rongan Business Overview
7.3.3 Ningbo Rongan Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.3.4 Ningbo Rongan Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.3.5 Ningbo Rongan Key News & Latest Developments
7.4 Hualan Bio-vaccine
7.4.1 Hualan Bio-vaccine Company Summary
7.4.2 Hualan Bio-vaccine Business Overview
7.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.4.5 Hualan Bio-vaccine Key News & Latest Developments
7.5 Sanofi Pasteur SA
7.5.1 Sanofi Pasteur SA Company Summary
7.5.2 Sanofi Pasteur SA Business Overview
7.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.5.5 Sanofi Pasteur SA Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Company Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.7.5 Bavarian Nordic Key News & Latest Developments
7.8 Serum Institute of India Pvt.
7.8.1 Serum Institute of India Pvt. Company Summary
7.8.2 Serum Institute of India Pvt. Business Overview
7.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.8.5 Serum Institute of India Pvt. Key News & Latest Developments
7.9 Chengdu Kanghua Biology
7.9.1 Chengdu Kanghua Biology Company Summary
7.9.2 Chengdu Kanghua Biology Business Overview
7.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.9.5 Chengdu Kanghua Biology Key News & Latest Developments
7.10 Changchun Zhuoyi Biology
7.10.1 Changchun Zhuoyi Biology Company Summary
7.10.2 Changchun Zhuoyi Biology Business Overview
7.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.10.5 Changchun Zhuoyi Biology Key News & Latest Developments
7.11 Dalian Yali Peak
7.11.1 Dalian Yali Peak Company Summary
7.11.2 Dalian Yali Peak Business Overview
7.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.11.5 Dalian Yali Peak Key News & Latest Developments
7.12 Jilin Huikang Biopharmaceutical Co., Ltd.
7.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Summary
7.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview
7.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2020-2025)
7.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Key News & Latest Developments
8 Global Human Rabies Vaccine (Vero Cell) Production Capacity, Analysis
8.1 Global Human Rabies Vaccine (Vero Cell) Production Capacity, 2020-2031
8.2 Human Rabies Vaccine (Vero Cell) Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Rabies Vaccine (Vero Cell) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Rabies Vaccine (Vero Cell) Supply Chain Analysis
10.1 Human Rabies Vaccine (Vero Cell) Industry Value Chain
10.2 Human Rabies Vaccine (Vero Cell) Upstream Market
10.3 Human Rabies Vaccine (Vero Cell) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Rabies Vaccine (Vero Cell) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Human Rabies Vaccine (Vero Cell) in Global Market
Table 2. Top Human Rabies Vaccine (Vero Cell) Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Human Rabies Vaccine (Vero Cell) Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Human Rabies Vaccine (Vero Cell) Revenue Share by Companies, 2020-2025
Table 5. Global Human Rabies Vaccine (Vero Cell) Sales by Companies, (K Units), 2020-2025
Table 6. Global Human Rabies Vaccine (Vero Cell) Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Human Rabies Vaccine (Vero Cell) Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Human Rabies Vaccine (Vero Cell) Product Type
Table 9. List of Global Tier 1 Human Rabies Vaccine (Vero Cell) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Rabies Vaccine (Vero Cell) Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 21. By Region – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 25. By Region - Global Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 26. By Country - North America Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 29. By Country - North America Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 30. By Country - Europe Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 33. By Country - Europe Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 34. By Region - Asia Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 37. By Region - Asia Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 38. By Country - South America Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 41. By Country - South America Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales, (K Units), 2026-2031
Table 46. Liaoning Chengda Company Summary
Table 47. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Offerings
Table 48. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Liaoning Chengda Key News & Latest Developments
Table 50. Guangzhou Nuocheng Company Summary
Table 51. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Offerings
Table 52. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Guangzhou Nuocheng Key News & Latest Developments
Table 54. Ningbo Rongan Company Summary
Table 55. Ningbo Rongan Human Rabies Vaccine (Vero Cell) Product Offerings
Table 56. Ningbo Rongan Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Ningbo Rongan Key News & Latest Developments
Table 58. Hualan Bio-vaccine Company Summary
Table 59. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Offerings
Table 60. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Hualan Bio-vaccine Key News & Latest Developments
Table 62. Sanofi Pasteur SA Company Summary
Table 63. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Offerings
Table 64. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Sanofi Pasteur SA Key News & Latest Developments
Table 66. Bharat Biotech Company Summary
Table 67. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Offerings
Table 68. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Bharat Biotech Key News & Latest Developments
Table 70. Bavarian Nordic Company Summary
Table 71. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Offerings
Table 72. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Bavarian Nordic Key News & Latest Developments
Table 74. Serum Institute of India Pvt. Company Summary
Table 75. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Offerings
Table 76. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Serum Institute of India Pvt. Key News & Latest Developments
Table 78. Chengdu Kanghua Biology Company Summary
Table 79. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Offerings
Table 80. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Chengdu Kanghua Biology Key News & Latest Developments
Table 82. Changchun Zhuoyi Biology Company Summary
Table 83. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Offerings
Table 84. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Changchun Zhuoyi Biology Key News & Latest Developments
Table 86. Dalian Yali Peak Company Summary
Table 87. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Offerings
Table 88. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Dalian Yali Peak Key News & Latest Developments
Table 90. Jilin Huikang Biopharmaceutical Co., Ltd. Company Summary
Table 91. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Offerings
Table 92. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Jilin Huikang Biopharmaceutical Co., Ltd. Key News & Latest Developments
Table 94. Human Rabies Vaccine (Vero Cell) Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 95. Global Human Rabies Vaccine (Vero Cell) Capacity Market Share of Key Manufacturers, 2023-2025
Table 96. Global Human Rabies Vaccine (Vero Cell) Production by Region, 2020-2025 (K Units)
Table 97. Global Human Rabies Vaccine (Vero Cell) Production by Region, 2026-2031 (K Units)
Table 98. Human Rabies Vaccine (Vero Cell) Market Opportunities & Trends in Global Market
Table 99. Human Rabies Vaccine (Vero Cell) Market Drivers in Global Market
Table 100. Human Rabies Vaccine (Vero Cell) Market Restraints in Global Market
Table 101. Human Rabies Vaccine (Vero Cell) Raw Materials
Table 102. Human Rabies Vaccine (Vero Cell) Raw Materials Suppliers in Global Market
Table 103. Typical Human Rabies Vaccine (Vero Cell) Downstream
Table 104. Human Rabies Vaccine (Vero Cell) Downstream Clients in Global Market
Table 105. Human Rabies Vaccine (Vero Cell) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Rabies Vaccine (Vero Cell) Product Picture
Figure 2. Human Rabies Vaccine (Vero Cell) Segment by Type in 2024
Figure 3. Human Rabies Vaccine (Vero Cell) Segment by Application in 2024
Figure 4. Global Human Rabies Vaccine (Vero Cell) Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Human Rabies Vaccine (Vero Cell) Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Human Rabies Vaccine (Vero Cell) Revenue: 2020-2031 (US$, Mn)
Figure 8. Human Rabies Vaccine (Vero Cell) Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Human Rabies Vaccine (Vero Cell) Revenue in 2024
Figure 10. Segment by Type – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Human Rabies Vaccine (Vero Cell) Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 21. By Region - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 22. By Country - North America Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 23. By Country - North America Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 24. United States Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 29. Germany Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 30. France Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Human Rabies Vaccine (Vero Cell) Sales Market Share, 2020-2031
Figure 38. China Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 42. India Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2020-2031
Figure 44. By Country - South America Human Rabies Vaccine (Vero Cell) Sales, Market Share, 2020-2031
Figure 45. Brazil Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales, Market Share, 2020-2031
Figure 49. Turkey Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Human Rabies Vaccine (Vero Cell) Revenue, (US$, Mn), 2020-2031
Figure 53. Global Human Rabies Vaccine (Vero Cell) Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Human Rabies Vaccine (Vero Cell) by Region, 2024 VS 2031
Figure 55. Human Rabies Vaccine (Vero Cell) Industry Value Chain
Figure 56. Marketing Channels
